Comparison of the effectiveness of ranibizumab monotherapy vs. combined panretinal photocoagulation on the regression of neovascularization in proliferative diabetic retinopathy.

Regarding NVE, while the proportion of patients with residual NVE was lower in the combined PRP group at both 12 months and 24 months, these differences did not reach statistical significance ( P = 0.097 and P = 0.095, respectively; Table 2 ). 3.3 Best corrected visual acuity The changes in BCVA (measured in ETDRS letters) for both groups are shown in Table 3 .

also in 111,027 other papers

High-risk PDR status (OR = 1.906, 95% CI 0.997–3.646, P = 0.051) and disrupted ellipsoid zone (OR=1.818, 95% CI 0.955–3.462, P = 0.069) showed a trend toward being risk factors but were no longer statistically significant in the multivariate model ( Table 6 ). 4 Discussion This retrospective study provides a comparative analysis of two contemporary management strategies for PDR over a 24-month period.

also in 53,322 other papers